SCHEMBL24065690

SCHEMBL24065690

Cc1ccc(N(c2ccc(C)cc2)c2cc(O)cc(N(c3ccc(C)cc3)c3ccc(C)cc3)c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACHE P22303 4/20 0.46
▸ ALDH1A1 P00352 5/20 0.42
▸ TSHR P16473 2/20 0.42
▸ TDP1 Q9NUW8 2/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ LPL P06858 1/20 0.36
▸ LIPG Q9Y5X9 1/20 0.36
▸ TRPA1 O75762 1/20 0.36
▸ ESR2 Q92731 1/20 0.35
▸ CYTH2 Q99418 1/20 0.35
▸ LMNA P02545 2/20 0.35
▸ ADRA1A P35348 4/20 0.35
▸ ADRA2A P08913 3/20 0.35
▸ ADRA1D P25100 3/20 0.35
▸ ADRA1B P35368 3/20 0.35
▸ ADRA2B P18089 2/20 0.35
▸ ADRA2C P18825 2/20 0.35
▸ HTR1A P08908 1/20 0.35
▸ ADORA3 P0DMS8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15424287 0.95 ACHE (0.46) ACHEALDH1A1TSHRTDP1CYP3A4
SCHEMBL313428 0.88 ALDH1A1 (0.52) ACHEALDH1A1TSHRTDP1CYP3A4
SCHEMBL8766259 0.83 ALDH1A1 (0.48) ACHEALDH1A1TSHRTDP1CYP3A4
SCHEMBL347583 0.83 ACHE (0.68) ACHEALDH1A1TSHRTDP1CYP3A4
SCHEMBL28032007 0.83 ACHE (0.68) ACHEALDH1A1TSHRTDP1CYP3A4
SCHEMBL3743294 0.83 ACHE (0.68) ACHEALDH1A1TSHRTDP1CYP3A4
SCHEMBL26578816 0.82 ACHE (0.50) ACHEALDH1A1TSHRTDP1CYP3A4
SCHEMBL26578818 0.82 ACHE (0.50) ACHEALDH1A1TSHRTDP1CYP3A4
SCHEMBL13608544 0.81 ALDH1A1 (0.46) ACHEALDH1A1TSHRTDP1CYP3A4
SCHEMBL997789 0.81 ALDH1A1 (0.46) ACHEALDH1A1TSHRTDP1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228514-A1 BORON-CONTAINING ORGANIC COMPOUND AND APPLICATIONS THEREOF SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2024-07-11 — — US disclosed
US-20240228514-A1 BORON-CONTAINING ORGANIC COMPOUND AND APPLICATIONS THEREOF SHENZHEN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD. (CN) 2024-07-11 — — US disclosed
US-20210376249-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2021-12-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240228514-A1 BORON-CONTAINING ORGANIC COMPOUND AND APPLICATIONS THEREOF BCL6, SLCO4C1, SLCO2B1 ACHE 1351/4885ALDH1A1 1928/4885TSHR 3807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback